| Literature DB >> 22855518 |
Adam P Barker1, Keith E Simmon, Sam Cohen, E Susan Slechta, Mark A Fisher, Robert Schlaberg.
Abstract
No clinical isolates have been reported for the recently described thermoactinomycete Kroppenstedtia eburnea. Between 2006 and 2011, we obtained 14 clinical isolates from patients in 9 U.S. states. Here we report growth characteristics, 16S rRNA gene sequencing, matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry-based identification, and antimicrobial susceptibility profiles of this recently described organism.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22855518 PMCID: PMC3457443 DOI: 10.1128/JCM.01186-12
Source DB: PubMed Journal: J Clin Microbiol ISSN: 0095-1137 Impact factor: 5.948